Novartis AG (NVS)
102.10
+1.90
(+1.89%)
USD |
NYSE |
May 10, 16:00
102.59
+0.48
(+0.48%)
After-Hours: 20:00
Novartis Price to Book Value: 5.251 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 5.154 |
May 08, 2024 | 5.122 |
May 07, 2024 | 5.095 |
May 06, 2024 | 5.026 |
May 03, 2024 | 5.002 |
May 02, 2024 | 5.006 |
May 01, 2024 | 5.014 |
April 30, 2024 | 4.995 |
April 29, 2024 | 4.993 |
April 26, 2024 | 5.011 |
April 25, 2024 | 5.094 |
April 24, 2024 | 5.058 |
April 23, 2024 | 5.003 |
April 22, 2024 | 4.892 |
April 19, 2024 | 4.853 |
April 18, 2024 | 4.761 |
April 17, 2024 | 4.787 |
April 16, 2024 | 4.793 |
April 15, 2024 | 4.855 |
April 12, 2024 | 4.810 |
April 11, 2024 | 4.852 |
April 10, 2024 | 4.854 |
April 09, 2024 | 4.927 |
April 08, 2024 | 4.910 |
April 05, 2024 | 4.926 |
Date | Value |
---|---|
April 04, 2024 | 4.983 |
April 03, 2024 | 4.853 |
April 02, 2024 | 4.855 |
April 01, 2024 | 4.930 |
March 31, 2024 | |
March 28, 2024 | 4.237 |
March 27, 2024 | 4.200 |
March 26, 2024 | 4.173 |
March 25, 2024 | 4.193 |
March 22, 2024 | 4.215 |
March 21, 2024 | 4.208 |
March 20, 2024 | 4.207 |
March 19, 2024 | 4.219 |
March 18, 2024 | 4.201 |
March 15, 2024 | 4.260 |
March 14, 2024 | 4.298 |
March 13, 2024 | 4.336 |
March 12, 2024 | 4.37 |
March 11, 2024 | 4.44 |
March 08, 2024 | 4.411 |
March 07, 2024 | 4.377 |
March 06, 2024 | 4.496 |
March 05, 2024 | 4.472 |
March 04, 2024 | 4.466 |
March 01, 2024 | 4.470 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.588
Minimum
Sep 26 2022
5.469
Maximum
Oct 02 2023
3.730
Average
3.783
Median
Sep 03 2021
Price to Book Value Benchmarks
Roche Holding AG | 5.656 |
Sandoz Group AG | -- |
Amgen Inc | 33.13 |
AstraZeneca PLC | 6.392 |
MorphoSys AG | 50.11 |
Price to Book Value Related Metrics
PE Ratio | 13.93 |
PS Ratio | 4.244 |
PEG Ratio | 0.1110 |
Price to Free Cash Flow | 20.68 |
Price | 102.10 |
Earnings Yield | 7.18% |
Market Cap | 208.34B |
PEGY Ratio | 0.1077 |
Operating PE Ratio | 19.92 |
Normalized PE Ratio | 23.10 |